Aptahem AB (XSAT:APTA) ROE % Adjusted to Book Value : -20.46% (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aptahem AB ROE % Adjusted to Book Value?

Aptahem AB's ROE % for the quarter that ended in Sep. 2024 was -7.57%. Aptahem AB's PB Ratio for the quarter that ended in Sep. 2024 was 0.37. Aptahem AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -20.46%.

Aptahem AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Aptahem AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptahem AB ROE % Adjusted to Book Value Chart

Aptahem AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-13.66

-27.16

-43.31

-14.02

-57.26

Aptahem AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-15.61	-89.44	-60.61	-62.37	-20.46

Competitive Comparison of Aptahem AB's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Aptahem AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptahem AB's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptahem AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Aptahem AB's ROE % Adjusted to Book Value falls into.

Aptahem AB ROE % Adjusted to Book Value Calculation

Aptahem AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-19.47%	/	0.34
	=	-57.26%

Aptahem AB's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-7.57%	/	0.37
	=	-20.46%

Aptahem AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Aptahem AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptahem AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptahem AB (XSAT:APTA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Norra Vallgatan 58, Malmo, SWE, 211 22

Website

http://www.aptahem.com

Aptahem AB develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's main candidate Apta-1 is developed as an emergency medicine intended to prevent the occurrence of life-threatening organ and tissue damage in patients suffering from sepsis.

Aptahem AB Headlines

No Headlines